InsiderTrades

Form 4 for TDOC Teladoc Health, Inc.

Accepted 2022-05-05 00:00:00 ET · period of report 2022-05-03 · accession 0001415889-22-004664 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-05-05 2022-05-04 TDOC Jensen Claus Torp Chief INNOVATION Off S - Sale+OE $37.85 -2,051 3,565 -37% -$77.6K
D 2022-05-05 2022-05-03 TDOC Jensen Claus Torp Chief INNOVATION Off M - OptEx — +5,616 5,616 New —
D 2022-05-05 2022-05-03 TDOC Jensen Claus Torp Chief INNOVATION Off M - OptEx $0.00 -5,616 11.2K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-05-04 S D 2,051 $37.85 3,565 D — — (F2) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
2 Common Common Stock 2022-05-03 M A 5,616 — 5,616 D — — (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
3 Derivative Restricted Stock Units 2022-05-03 M D 5,616 $0.00 11,233 D — · — to — 5,616 Common Stock (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F3) On May 3, 2021, the reporting person was granted 16,849 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.